Dyslipidemia, but not hyperglycemia and insulin resistance, is associated with marked alterations in the HDL lipidome in type 2 diabetic subjects in the DIWA cohort: impact on small HDL particles.

[1]  P. Meikle,et al.  Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance , 2013, Diabetes.

[2]  Zahi A Fayad,et al.  Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. , 2012, Circulation.

[3]  B. Fagerberg,et al.  Clinical dyslipidaemia is associated with changes in the lipid composition and inflammatory properties of apolipoprotein-B-containing lipoproteins from women with type 2 diabetes , 2012, Diabetologia.

[4]  A. Kontush,et al.  High-Density Lipoproteins: Structure, Metabolism, Function and Therapeutics , 2012 .

[5]  E. Ferrannini,et al.  Anti-inflammatory and Antioxidant Properties of HDLs Are Impaired in Type 2 Diabetes , 2011, Diabetes.

[6]  J. Borén,et al.  Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management , 2011, European heart journal.

[7]  A. von Eckardstein,et al.  Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2 , 2011, Current opinion in lipidology.

[8]  Robert L Wilensky,et al.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.

[9]  L. Curtiss,et al.  Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma , 2010, Nature Structural &Molecular Biology.

[10]  Perttu S. Niemelä,et al.  Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol[S] , 2010, Journal of Lipid Research.

[11]  P. Barter,et al.  Effects of High-Density Lipoproteins on Pancreatic &bgr;-Cell Insulin Secretion , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[12]  Costantina Manes,et al.  Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy , 2010, Circulation.

[13]  M. Couturier,et al.  HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity: Relevance to Inflammation and Atherogenesis , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[14]  D. Sviridov,et al.  High-Density Lipoprotein Modulates Glucose Metabolism in Patients With Type 2 Diabetes Mellitus , 2009, Circulation.

[15]  M. Mackness,et al.  Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[16]  A. Kontush,et al.  Why is HDL functionally deficient in type 2 diabetes? , 2008, Current diabetes reports.

[17]  B. Fagerberg,et al.  Proteomics and lipids of lipoproteins isolated at low salt concentrations in D2O/sucrose or in KBr Published, JLR Papers in Press, November 18, 2007. , 2008, Journal of Lipid Research.

[18]  A. Kontush,et al.  Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis , 2006, Pharmacological Reviews.

[19]  Kai Simons,et al.  Automated identification and quantification of glycerophospholipid molecular species by multiple precursor ion scanning. , 2006, Analytical chemistry.

[20]  P. Gambert,et al.  Inability of HDL from type 2 diabetic patients to counteract the inhibitory effect of oxidised LDL on endothelium-dependent vasorelaxation , 2006, Diabetologia.

[21]  C. Behre,et al.  Prevalence of diabetes and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests. , 2006, Diabetes care.

[22]  N. Webb.  Secretory phospholipase A2 enzymes in atherogenesis , 2005, Current opinion in lipidology.

[23]  B. Hansel,et al.  Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia , 2005, Diabetologia.

[24]  D. Ng.  Insight into the Role of LCAT from Mouse Models , 2004, Reviews in Endocrine and Metabolic Disorders.

[25]  Philippe Giral,et al.  Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity. , 2004, The Journal of clinical endocrinology and metabolism.

[26]  M. Hersberger,et al.  High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease , 2004, Current opinion in lipidology.

[27]  Christer S. Ejsing,et al.  Charting molecular composition of phosphatidylcholines by fatty acid scanning and ion trap MS3 fragmentation Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.D300020-JLR200 , 2003, Journal of Lipid Research.

[28]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  M. Taskinen.  Diabetic dyslipidaemia: from basic research to clinical practice* , 2003, Diabetologia.

[30]  B. Vessby,et al.  Desaturation and Elongation of Fatty Acids and Insulin Action , 2002, Annals of the New York Academy of Sciences.

[31]  A. van Tol,et al.  Proatherogenic Role of Elevated CE Transfer From HDL to VLDL1 and Dense LDL in Type 2 Diabetes: Impact of the Degree of Triglyceridemia , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[32]  P. Sartipy,et al.  Phospholipase A2 and small, dense low-density lipoprotein , 2000, Current opinion in lipidology.

[33]  G. Bondjers,et al.  LDL particle size in relation to intima‐media thickness and plaque occurrence in the carotid and femoral arteries in patients with hypercholesterolaemia , 2000, Journal of internal medicine.

[34]  D. Rader,et al.  Overexpression of Secretory Phospholipase A2 Causes Rapid Catabolism and Altered Tissue Uptake of High Density Lipoprotein Cholesteryl Ester and Apolipoprotein A-I* , 2000, The Journal of Biological Chemistry.

[35]  B. Fagerberg,et al.  Computerized measurement of LDL particle size in human serum. Reproducibility studies and evaluation of LDL particle size in relation to metabolic variables and the occurrence of atherosclerosis. , 1999, Scandinavian journal of clinical and laboratory investigation.

[36]  James W. Anderson,et al.  Decreased protection by HDL from poorly controlled type 2 diabetic subjects against LDL oxidation may Be due to the abnormal composition of HDL. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[37]  G. Ponsin,et al.  Distribution of diacylglycerols among plasma lipoproteins in control subjects and in patients with non‐insulin‐dependent diabetes , 1999, European journal of clinical investigation.

[38]  R. Homan,et al.  Rapid separation and quantitation of combined neutral and polar lipid classes by high-performance liquid chromatography and evaporative light-scattering mass detection. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[39]  J. Fruchart,et al.  Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[40]  J. Ibdah,et al.  Effects of lipid composition and packing on the adsorption of apolipoprotein A-I to lipid monolayers. , 1988, Biochemistry.

[41]  R. Tilvis,et al.  Fatty acid compositions of serum lipids, erythrocytes, and platelets in insulin-dependent diabetic women. , 1985, The Journal of clinical endocrinology and metabolism.

[42]  S. Robins,et al.  Origin of plasma lysophosphatidylcholine: evidence for direct hepatic secretion in the rat. , 1985, The Journal of laboratory and clinical medicine.

[43]  S. Goldstein,et al.  A density gradient ultracentrifugal procedure for the isolation of the major lipoprotein classes from human serum. , 1981, Journal of lipid research.

[44]  J. Folch,et al.  A simple method for the isolation and purification of total lipides from animal tissues. , 1957, The Journal of biological chemistry.

[45]  P. Toth.  Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis , 2011 .

[46]  H. Callender,et al.  Quantification of diacylglycerol species from cellular extracts by electrospray ionization mass spectrometry using a linear regression algorithm. , 2007, Analytical chemistry.

[47]  Gerd Schmitz,et al.  High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). , 2006, Biochimica et biophysica acta.

[48]  J. Rood,et al.  Relationship of dietary fat and serum cholesterol ester and phospholipid fatty acids to markers of insulin resistance in men and women with a range of glucose tolerance. , 2001, Metabolism: clinical and experimental.